On 28 July, the European Commission signed a contract with the pharmaceutical company Gilead to secure treatment doses of Veklury, the brand name for Remdesivir. As...
As of 3 July, the European Commission granted a conditional marketing authorization for the medicine Remdesivir, making it the first medicine authorized at EU level for...
